Ad is loading...
ERHSX
Price
$15.08
Change
-$0.37 (-2.39%)
Updated
Nov 15 closing price
VGHCX
Price
$204.50
Change
-$5.96 (-2.83%)
Updated
Nov 15 closing price
Ad is loading...

ERHSX vs VGHCX

Header iconERHSX vs VGHCX Comparison
Open Charts ERHSX vs VGHCXBanner chart's image
Eaton Vance Worldwide Health Sci R
Price$15.08
Change-$0.37 (-2.39%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$204.50
Change-$5.96 (-2.83%)
VolumeN/A
CapitalizationN/A
ERHSX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ERHSX vs. VGHCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERHSX is a StrongSell and VGHCX is a Sell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 45.7B vs. ERHSX (1.02B). VGHCX pays higher dividends than ERHSX: VGHCX (0.79) vs ERHSX (0.00). ERHSX was incepted earlier than VGHCX: ERHSX (21 years) vs VGHCX (41 years). ERHSX is a more actively managed with annual turnover of: 21.00 vs. VGHCX (16.00). ERHSX has a lower initial minimum investment than VGHCX: ERHSX (1000) vs VGHCX (3000). ERHSX annual gain was more profitable for investors over the last year : 10.31 vs. VGHCX (1.65). ERHSX return over 5 years is better than : 14.88 vs. VGHCX (-2.73).
ERHSXVGHCXERHSX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years41 years-
Gain YTD5.750-2.205-261%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B45.7B2%
Annual Yield % from dividends0.000.79-
Returns for 1 year10.311.65627%
Returns for 3 years-8.61-13.8562%
Returns for 5 years14.88-2.73-546%
Returns for 10 years0.46-9.94-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.31-0.24
-0.54%
UDR
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
OI12.97-0.17
-1.29%
O-I Glass
VIRX0.15-0.01
-4.37%
Viracta Therapeutics
PEPG4.12-0.37
-8.24%
PepGen